Impact of sex hormones on immune function and multiple sclerosis development
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Summary: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) affecting young people and leading to demyelination and neurodegeneration. The disease is clearly more common in women, in whom incidence has been rising. Gender differences include: earlier disease onset and more frequent relapses in women; and faster progression and worse outcomes in men. Hormone‐related physiological conditions in women such as puberty, pregnancy, puerperium, and menopause also exert significant influence both on disease prevalence as well as on outcomes. Hormonal and/or genetic factors are therefore believed to be involved in regulating the course of disease. In this review, we discuss clinical evidence for the impact of sex hormones (estrogens, progesterone, prolactin, and testosterone) on MS and attempt to elucidate the hormonal and immunological mechanisms potentially underlying these changes. We also review current knowledge on the relationship between sex hormones and resident CNS cells and provide new insights in the context of MS. Understanding these molecular mechanisms may contribute to the development of new and safer treatments for both men and women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457
The changing demographic pattern of multiple sclerosis epidemiology
Koch-Henriksen, N., & Sørensen, P. S. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70064-8 · Cited by 1,191
Treatment of multiple sclerosis with the pregnancy hormone estriol
Sicotte, N. L., Liva, S. M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T. C. J., & Voskuhl, R. R. (2002) · Annals of Neurology · doi:10.1002/ana.10301 · Cited by 435
Estriol ameliorates autoimmune demyelinating disease: Implications for multiple sclerosis
Kim, S., Liva, S. M., Dalal, M. A., Verity, M. A., & Voskuhl, R. R. (1999) · Neurology · doi:10.1212/wnl.52.6.1230 · Cited by 268
Ribbons, K. A., McElduff, P., Boz, C., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Grand’Maison, F., Hupperts, R., Grammond, P., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122686 · Cited by 190
‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence
Pozzilli, C., Tomassini, V., Marinelli, F., Paolillo, A., Gasperini, C., & Bastianello, S. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00519.x · Cited by 154
Gender differences in autoimmune demyelination in the mouse: Implications for multiple sclerosis
Voskuhl, R. R., Pitchekian‐Halabi, H., Mackenzie‐Graham, A., McFarland, H. F., & Raine, C. S. (1996) · Annals of Neurology · doi:10.1002/ana.410390608 · Cited by 143
Increase in multiple sclerosis activity after assisted reproduction technology
Correale, J., Farez, M. F., & Ysrraelit, M. C. (2012) · Annals of Neurology · doi:10.1002/ana.23745 · Cited by 134
Self-citationProlactin and Neuroimmunomodulation: In Vitro and in Vivo Observations
CHIKANZA, I. C. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07629.x · Cited by 132
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
Noorbakhsh, F., Baker, G. B., & Power, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00134 · Cited by 95
Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells
Benedek, G., Zhang, J., Nguyen, H., Kent, G., Seifert, H. A., Davin, S., Stauffer, P., Vandenbark, A. A., Karstens, L., Asquith, M., et al. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.06.007 · Cited by 64
Breastfeeding, ovulatory years, and risk of multiple sclerosis
Langer-Gould, A., Smith, J. B., Hellwig, K., Gonzales, E., Haraszti, S., Koebnick, C., & Xiang, A. (2017) · Neurology · doi:10.1212/wnl.0000000000004207 · Cited by 60
Cited by
A direct effect of sex hormones on epithelial barrier function in inflammatory bowel disease models
van der Giessen, J., van der Woude, C. J., Peppelenbosch, M. P., & Fuhler, G. M. (2019) · Cells · doi:10.3390/cells8030261 · Cited by 88
Relapsing and progressive MS: the sex-specific perspective
Rommer, P. S., Ellenberger, D., Hellwig, K., Haas, J., Pöhlau, D., Stahmann, A., Zettl, U. K., & on behalf of the Scientific Advisory Group of the German MS-Register by the German MS Society (2020) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286420956495 · Cited by 37
Gut microbiota in multiple sclerosis and animal models
Schumacher, S. M., Doyle, W. J., Hill, K., & Ochoa‐Repáraz, J. (2025) · The FEBS Journal · doi:10.1111/febs.17161 · Cited by 21
Pike, S. C., Welsh, N., Linzey, M., & Gilli, F. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1019799 · Cited by 22
Omura, S., Sato, F., Martinez, N. E., Park, A.-M., Fujita, M., Kennett, N. J., Cvek, U., Minagar, A., Alexander, J. S., & Tsunoda, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00516 · Cited by 20
“Prolactin is secreted not only by the anterior pituitary but also extra-pituitary tissues including immune cells, while prolactin receptor is found on lymphocytes and other immune cells (76).”
Background
Metadata
- Authors
- Ysrraelit, M. C., & Correale, J.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2018-10-11
- Volume
- 156
- Issue
- 1
- Pages
- 9-22
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W2890913412
- Cited by
- 251
- References
- 12
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.